Nuwellis PE Ratio 2011-2025 | NUWE
Current and historical p/e ratio for Nuwellis (NUWE) from 2011 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nuwellis PE ratio as of July 23, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Nuwellis PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-23 | 13.83 | 0.00 | |
| 2025-03-31 | 39.48 | $-766.39 | 0.00 |
| 2024-12-31 | 46.62 | $-1,618.87 | 0.00 |
| 2024-09-30 | 49.98 | $-4,891.22 | 0.00 |
| 2024-06-30 | 211.26 | $-7,623.44 | 0.00 |
| 2024-03-31 | 522.61 | $-12,193.70 | 0.00 |
| 2023-12-31 | 853.92 | $-19,774.37 | 0.00 |
| 2023-09-30 | 2102.10 | $-23,829.12 | 0.00 |
| 2023-06-30 | 3954.30 | $-75,527.39 | 0.00 |
| 2023-03-31 | 7144.20 | $-130,398.99 | 0.00 |
| 2022-12-31 | 15758.40 | $-183,639.83 | 0.00 |
| 2022-09-30 | 79277.10 | $-236,528.11 | 0.00 |
| 2022-06-30 | 86568.30 | $-292,354.62 | 0.00 |
| 2022-03-31 | 148470.00 | $-337,897.35 | 0.00 |
| 2021-12-31 | 167580.00 | $-459,834.27 | 0.00 |
| 2021-09-30 | 323400.00 | $-565,610.90 | 0.00 |
| 2021-06-30 | 617400.00 | $-761,003.80 | 0.00 |
| 2021-03-31 | 868770.00 | $-1,096,404.10 | 0.00 |
| 2020-12-31 | 1000000.00 | $-2,545,119.20 | 0.00 |
| 2020-09-30 | 1000000.00 | $-7,320,290.70 | 0.00 |
| 2020-06-30 | 1000000.00 | $-14,514,721.90 | 0.00 |
| 2020-03-31 | 1000000.00 | $-22,588,259.00 | 0.00 |
| 2019-12-31 | 1000000.00 | $-22,160,255.00 | 0.00 |
| 2019-09-30 | 1000000.00 | $-54,145,583.00 | 0.00 |
| 2019-06-30 | 1000000.00 | $-84,337,155.00 | 0.00 |
| 2019-03-31 | 1000000.00 | $-77,190,089.00 | 0.00 |
| 2018-12-31 | 1000000.00 | $-77,573,975.00 | 0.00 |
| 2018-09-30 | 1000000.00 | $-55,353,365.00 | 0.00 |
| 2018-06-30 | 1000000.00 | $-24,352,969.00 | 0.00 |
| 2018-03-31 | 1000000.00 | $-36,808,861.00 | 0.00 |
| 2017-12-31 | 1000000.00 | $-86,691,264.00 | 0.00 |
| 2017-09-30 | 1000000.00 | $-208,456,064.00 | 0.00 |
| 2017-06-30 | 1000000.00 | $-440,238,880.00 | 0.00 |
| 2017-03-31 | 1000000.00 | $-629,559,840.00 | 0.00 |
| 2016-12-31 | 1000000.00 | $-807,730,800.00 | 0.00 |
| 2016-09-30 | 1000000.00 | $-989,225,400.00 | 0.00 |
| 2016-06-30 | 1000000.00 | $-1,068,716,700.00 | 0.00 |
| 2016-03-31 | 1000000.00 | $-1,174,705,100.00 | 0.00 |
| 2015-12-31 | 1000000.00 | $-1,298,358,300.00 | 0.00 |
| 2015-09-30 | 1000000.00 | $-1,333,687,800.00 | 0.00 |
| 2015-06-30 | 1000000.00 | $-1,333,687,800.00 | 0.00 |
| 2015-03-31 | 1000000.00 | $-1,360,185,000.00 | 0.00 |
| 2014-12-31 | 1000000.00 | $-1,342,520,300.00 | 0.00 |
| 2014-09-30 | 1000000.00 | $-1,360,185,000.00 | 0.00 |
| 2014-06-30 | 1000000.00 | $-1,457,341,100.00 | 0.00 |
| 2014-03-31 | 1000000.00 | $-1,430,843,900.00 | 0.00 |
| 2013-12-31 | 1000000.00 | $-1,510,335,200.00 | 0.00 |
| 2013-09-30 | 1000000.00 | $-1,528,000,000.00 | 0.00 |
| 2013-06-30 | 1000000.00 | $-1,483,838,100.00 | 0.00 |
| 2013-03-31 | 1000000.00 | $-1,545,664,700.00 | 0.00 |
| 2012-12-31 | 1000000.00 | $-1,713,479,700.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.001B | $0.009B |
| Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for ultrafiltration therapy. Nuwellis Inc., formerly known as CHF Solutions, is headquartered in Minneapolis, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.152B | 75.93 |
| Thermo Fisher Scientific (TMO) | United States | $161.424B | 19.53 |
| Edwards Lifesciences (EW) | United States | $44.758B | 29.35 |
| Alcon (ALC) | Switzerland | $43.731B | 29.55 |
| IDEXX Laboratories (IDXX) | United States | $42.784B | 49.17 |
| DexCom (DXCM) | United States | $33.376B | 51.59 |
| IQVIA Holdings (IQV) | United States | $32.417B | 18.00 |
| Mettler-Toledo (MTD) | United States | $25.333B | 30.13 |
| STERIS (STE) | Ireland | $22.005B | 24.24 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.444B | 0.00 |
| Waters (WAT) | United States | $17.106B | 24.14 |
| Hologic (HOLX) | United States | $14.567B | 15.83 |
| Sysmex ADR (SSMXY) | Japan | $10.191B | 28.91 |
| Penumbra (PEN) | United States | $8.980B | 70.48 |
| Masimo (MASI) | United States | $8.579B | 31.65 |
| Globus Medical (GMED) | United States | $7.176B | 17.10 |
| Glaukos (GKOS) | United States | $5.506B | 0.00 |
| Teleflex (TFX) | United States | $5.091B | 8.40 |
| Integer Holdings (ITGR) | United States | $3.989B | 20.90 |
| TransMedics (TMDX) | United States | $3.572B | 77.65 |
| PROCEPT BioRobotics (PRCT) | United States | $3.251B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.375B | 14.14 |
| Nihon Kohden (NHNKY) | Japan | $2.079B | 23.85 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Veracyte (VCYT) | United States | $1.841B | 25.83 |
| Alphatec Holdings (ATEC) | United States | $1.570B | 0.00 |
| Artivion (AORT) | United States | $1.298B | 121.60 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.020B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.020B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.936B | 4.98 |
| SiBone (SIBN) | United States | $0.731B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 36.32 |
| Beta Bionics (BBNX) | United States | $0.649B | 0.00 |
| AxoGen (AXGN) | United States | $0.571B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.554B | 11.93 |
| OrthoPediatrics (KIDS) | United States | $0.553B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.547B | 8.51 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.435B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.393B | 9.13 |
| Delcath Systems (DCTH) | United States | $0.386B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.314B | 0.00 |
| NeuroPace (NPCE) | United States | $0.307B | 0.00 |
| RxSight (RXST) | United States | $0.295B | 0.00 |
| Neuronetics (STIM) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.259B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.07 |
| CVRx (CVRX) | United States | $0.210B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.167B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 45.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Spectral AI (MDAI) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.31 |